Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rigel Pharmaceuticals, Inc. RIGL

Set alert

Price alert · RIGL

All alert types
48.62 USD -1.91 -3.79%

As of Nov 3, 3:13 PM ET

Bid
48.41 × 1
Ask
48.79 × 2
46.88 Day range 51.29
24.95 52-week range 52.61
YTD
+13.51%
1 year
+58.61%
Open
50.44
Prev close
50.53
Mkt cap
907.28M
Vol
196.85K
Avg vol
259.24K
EPS
16.88
P/E
2.88
Div yield
0.00%
More statistics
Low
46.88
High
51.29
Forward P/E
19.49
Beta
0.95
Short ratio
1.69
Inst. own
68.01%
Dividend
0.00
Ex-div date
50-d avg
20.01
200-d avg
13.77
1y target
31.33

30m chart

Chart tools
Interval
1m5m15m30m

Built from the cached five-day intraday bars.

Signals (24)
NameTimeAgo
MACD: Buy SignalNov 2, 4:00 PM23 hours ago
SMA: BullishNov 2, 2:40 PM1 day ago
SMA: BearishNov 2, 9:55 AM1 day ago
SMA: BearishNov 2, 9:55 AM1 day ago
SMA: BullishOct 30, 3:55 PM4 days ago
SMA: BullishOct 30, 3:50 PM4 days ago
SMA: BearishOct 30, 2:50 PM4 days ago
SMA: BearishOct 30, 1:05 PM4 days ago
SMA: BullishOct 30, 12:35 PM4 days ago
SMA: BullishOct 30, 12:35 PM4 days ago
SMA: BearishOct 30, 12:00 PM4 days ago
SMA: BearishOct 30, 12:00 PM4 days ago
MACD: Sell SignalOct 30, 12:00 PM4 days ago
SMA: BullishOct 30, 10:50 AM4 days ago
SMA: BearishOct 30, 10:25 AM4 days ago
RSI: OverboughtOct 30, 9:55 AM4 days ago
MACD: Buy SignalOct 29, 3:55 PM5 days ago
SMA: BullishOct 29, 2:55 PM5 days ago
SMA: BearishOct 29, 12:05 PM5 days ago
SMA: BullishOct 28, 3:55 PM6 days ago

Newest 20 of 24.

Analyst view

Consensus: buy

Buy
Price target (mean) 31.33 -35.5% downside
Target (low)
14.00
Target (mean)
31.33
Target (high)
57.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold4
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6
  • 3 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RIGL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.334010.13 – 0.590.000.0%47.42M+32.5%5
Next quarter0.180.18 – 0.18-0.50+136.0%43.49M+47.3%1
Current year0.240860.09 – 0.37-1.40+117.2%169.10M+44.7%5
Next year1.040.53 – 1.610.24086+331.4%193.51M+14.4%5

Upgrades and downgrades

The latest rating changes

RIGL analyst upgrades and downgrades
DateFirmActionFromTo
Dec 10, 2024Cantor FitzgeraldMaintainedNeutralNeutral
Dec 10, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Dec 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 6, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Nov 14, 2024Piper SandlerMaintainedNeutralNeutral
Nov 12, 2024CitigroupMaintainedBuyBuy
Oct 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 9, 2024HC Wainwright & Co.MaintainedBuyBuy
Jun 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 3, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 7, 2024CitigroupMaintainedBuyBuy
Mar 6, 2024Cantor FitzgeraldMaintainedNeutralNeutral
Mar 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 6, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Feb 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 2, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 3, 2023HC Wainwright & Co.Reiterated—Buy
Mar 9, 2023CitigroupMaintained—Buy
Mar 8, 2023HC Wainwright & Co.Reiterated—Buy
Dec 2, 2022CitigroupUpgradeNeutralBuy
Nov 4, 2022BMO CapitalMaintained—Outperform
Aug 18, 2022HC Wainwright & Co.Maintained—Buy
Aug 17, 2022Piper SandlerMaintained—Neutral
Jun 9, 2022BMO CapitalMaintained—Outperform
Jun 9, 2022B. Riley SecuritiesMaintained—Neutral
Jun 9, 2022CitigroupDowngradeBuyNeutral